Department of Palliative Care, Rehabilitation, and Integrative Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Cancer. 2020 Jan 1;126(9):2013-2023. doi: 10.1002/cncr.32738. Epub 2020 Feb 12.
This study examined the changes in outpatient palliative care services at US cancer centers over the past decade.
Between April and August 2018, all National Cancer Institute (NCI)-designated cancer centers and a random sample of 1252 non-NCI-designated cancer centers were surveyed. Two surveys used previously in a 2009 national study were sent to each institution: a 22-question cancer center executive survey regarding palliative care infrastructure and attitudes toward palliative care and an 82-question palliative care program leader survey regarding detailed palliative care structures and processes. Survey findings from 2018 were compared with 2009 data from 101 cancer center executives and 96 palliative care program leaders.
The overall response rate was 69% (140 of 203) for the cancer center executive survey and 75% (123 of 164) for the palliative care program leader survey. Among NCI-designated cancer centers, a significant increase in outpatient palliative care clinics was observed between 2009 and 2018 (59% vs 95%; odds ratio, 12.3; 95% confidence interval, 3.2-48.2; P < .001) with no significant changes in inpatient consultation teams (92% vs 90%; P = .71), palliative care units (PCUs; 26% vs 40%; P = .17), or institution-operated hospices (31% vs 18%; P = .14). Among non-NCI-designated cancer centers, there was no significant increase in outpatient palliative care clinics (22% vs 40%; P = .07), inpatient consultation teams (56% vs 68%; P = .27), PCUs (20% vs 18%; P = .76), or institution-operated hospices (42% vs 23%; P = .05). The median interval from outpatient palliative care referral to death increased significantly, particularly for NCI-designated cancer centers (90 vs 180 days; P = 0.01).
Despite significant growth in outpatient palliative care clinics, there remain opportunities for improvement in the structures and processes of palliative care programs.
本研究考察了过去十年间美国癌症中心的门诊姑息治疗服务的变化。
2018 年 4 月至 8 月期间,对所有美国国立癌症研究所(NCI)指定的癌症中心和随机抽取的 1252 家非 NCI 指定的癌症中心进行了调查。向每个机构发送了两份之前在 2009 年全国性研究中使用过的调查:一份是关于姑息治疗基础设施和对姑息治疗态度的 22 个问题的癌症中心主管调查,另一份是关于姑息治疗结构和流程的 82 个问题的姑息治疗项目负责人调查。2018 年的调查结果与 2009 年 101 位癌症中心主管和 96 位姑息治疗项目负责人的数据进行了比较。
癌症中心主管调查的总体回复率为 69%(140/203),姑息治疗项目负责人调查的回复率为 75%(123/164)。在 NCI 指定的癌症中心中,2009 年至 2018 年间,门诊姑息治疗诊所的数量显著增加(59%比 95%;优势比,12.3;95%置信区间,3.2-48.2;P<.001),而住院咨询团队(92%比 90%;P=.71)、姑息治疗病房(PCU;26%比 40%;P=.17)或机构运营的临终关怀机构(31%比 18%;P=.14)没有显著变化。在非 NCI 指定的癌症中心中,门诊姑息治疗诊所的数量没有显著增加(22%比 40%;P=.07),住院咨询团队(56%比 68%;P=.27)、PCU(20%比 18%;P=.76)或机构运营的临终关怀机构(42%比 23%;P=.05)也没有显著增加。从门诊姑息治疗转介到死亡的中位时间间隔显著增加,尤其是 NCI 指定的癌症中心(90 天比 180 天;P=.01)。
尽管门诊姑息治疗诊所的数量显著增加,但姑息治疗项目的结构和流程仍有改进的空间。